HistoSonics Edison System for Treatment of Liver Tumors Across Users

Short Title: BOOMBOX

Enrollment Status: Recruiting

NCT #: NCT06486454

Specialty Area: Oncology

Conditions Studied: Primary Liver Cancer; Secondary Liver Cancer; Liver Neoplasms; Tumor Liver; Benign Liver Tumor

Age Groups: Adult; Older Adult

Phase: Not Applicable

Study Information

Summary / Purpose

To find out how well the HistoSonics Edison System works in treating liver tumors and how patient and procedural factors affect treatment success.

Study Type: Observational

Accepts Healthy Volunteers: No

Who Can Participate

Eligibility Criteria:

Adults 22+ years of age
Diagnosed with a liver tumor (primary, secondary, or benign)
Eligible for treatment using the HistoSonics Edison System

What's Involved

Participation in the study will include:

Treatment with the HistoSonics Edison System using histotripsy
Imaging tests (CT or MRI) to assess treatment success within 36 hours
Collection of medical information before, during, and after the procedure
Follow-up visits based on standard clinical practice for up to 5 years
Possible enrollment in sub-studies with additional procedures or testing

Principal Investigator

Nicholas Manguso, MD

Surgical Oncology

A Member of

(775) 982–6270

Renown Surgery Care

View Provider

Additional Information

Location: Renown Health, Office of Clinical Research
Address:

1500 E 2nd St. Reno, NV 89502

General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org

Complete Study Details: https://clinicaltrials.gov/study/NCT06486454

Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.

Health & Wellness eNews